Hans C. Diener - Publications

Kidney disease increases the risk of cardiovascular events in patients with device-detected atrial fibrillation: NOAH-AFNET 6.

Journal: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology

Published: March 03, 2026

Drugs for Migraine Prophylaxis.

Journal: Deutsches Arzteblatt international

Published: January 23, 2026

Moderate to Severe Acute Migraine Attacks: An Opinion Paper on the Use of Triptans and Triptan-NSAIDs Combinations in Individualized Treatment Plans.

Journal: Neurology and therapy

Published: November 03, 2025

Effects of anticoagulation in patients with device-detected atrial fibrillation and multiple stroke risk factors: a win ratio analysis of the NOAH-AFNET 6 trial.

Journal: European heart journal. Quality of care & clinical outcomes

Published: August 05, 2025

Dopamine and prolactin in migraine: Mechanisms and potential therapeutic targets.

Journal: Journal of neuroendocrinology

Published: July 15, 2025

Asian-Pacific Expert Opinion on Patent Foramen Ovale Closure: Review of New Evidence and Focused Update.

Journal: Journal of stroke

Published: June 26, 2025

PACAP and migraine.

Journal: Brain : a journal of neurology

Published: March 17, 2025

Anticoagulation in Patients With Device-Detected Atrial Fibrillation With and Without a Prior Stroke or Transient Ischemic Attack: The NOAH-AFNET 6 Trial.

Journal: Journal of the American Heart Association

Published: August 27, 2024

Sumatriptan-naproxen sodium in migraine: A review.

Journal: European journal of neurology

Published: June 05, 2024

New migraine drugs: A critical appraisal of the reason why the majority of migraine patients do not receive an adequate medication.

Journal: Cephalalgia : an international journal of headache

Published: March 23, 2024

Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial.

Journal: European heart journal

Published: February 13, 2024

Anticoagulation with edoxaban in patients with long atrial high-rate episodes ≥24 h.

Journal: European heart journal

Published: October 24, 2023